Another study showed that newly diagnosed MM patients with false-negative findings on FDG PET/CT had longer PFS than FDG-positive patients [30]; however, other mechanisms also appear to be involved in the uptake as FDG-negative patients with relapsed/refractory disease were found to have normal expression of Hexokinase-2 [31]. This evidence concerns the gene HK2 and Miyoshi myopathy.